Navigation Links
Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor
Date:10/29/2009

ho Therapeutics

Echo Therapeutics is focused on medical devices and specialty pharmaceuticals. Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies, including the efficacy of Echo's Symphony tCGM System, the failure of future development and preliminary marketing efforts related to Echo's Symphony tCGM System, Echo's ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Echo's ability to develop, market and sell diagnostic and transdermal drug delivery products based on its skin permeation platform technologies, including the Symphony tCGM System, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its Symphony tCGM System. These and other risks and uncertainties are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual r
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
2. Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study
3. Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
4. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
5. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum
6. Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders
7. Logical Therapeutics to Present Data on LT-NS001 at American College of Gastroenterology Annual Meeting
8. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
9. Oxygen Biotherapeutics, Inc. to Webcast Shareholder Meeting
10. ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
11. Prime Therapeutics Receives 2010 TIPPS Certification for Adherence to High Transparency Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 25, 2015 Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ... by Technology, Imaging and by Application - Forecast to 2020" ... is expected to reach $13.1 Billion in 2020 from an estimated ... The market is dominated by North America ... , and Rest of the World (RoW). The cancer diagnostics ...
(Date:7/2/2015)... Mass. , July 2, 2015   ... and European retinal specialists identify less frequent dosing ... edema (DME), due to the burden on both ... anti-vascular endothelial growth factor (VEGF) injections, which are ... Allergan/Molecular Partners, abicipar pegol, which is in development ...
(Date:7/2/2015)... 2015 BGI gab heute bekannt, ... vom American College of Pathologists (CAP) akkreditiert ... erste klinische Next-Generation-Sequencing Labor, das in ... und somit die höchsten Standards an klinischer ... FDA - 21 CFR Part 11 konformen ...
Breaking Medicine Technology:Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
... MOUNTAIN VIEW, Calif., April 28, 2011 IRIDEX Corporation (NASDAQ: ... quarter 2011 financial results after the market closes on ... the Company will host a conference call with the investment community ... Thursday, May 5, 2011 to discuss the results ...
... April 28, 2011 PharmaNet Development Group, Inc., a ... generic drug and medical device companies, announced today that ... President, Corporate Quality Assurance. "We are ... Newman, MD, President, PharmaNet Development Group. "Valerie brings deep ...
Cached Medicine Technology:
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... New Albany, MS 38652, will have a grand opening event on July 4, 2015 ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... the Lone Star State. The premium frozen yogurt chain was listed as #22 on ... opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite ...
(Date:7/2/2015)... ... July 02, 2015 , ... The American Association of ... the Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together ... seeks to decrease drug overdose – especially of heroin and opioid medication – ...
(Date:7/2/2015)... Lincoln, RI (PRWEB) , ... July 02, 2015 , ... ... keep safety in mind. That’s why Amica Insurance is sharing some tips ... Safety Commission (CPSC), approximately 230 people go to the emergency room daily with fireworks-related ...
(Date:7/2/2015)... , ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift ... alone. He sat down to write his first poem, and three years later he was ... was special and worth sharing with the world. "I have always believed that the best ...
Breaking Medicine News(10 mins):Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
... PRESSURE DOES NOT PREDICT EFFECT ON HEART IN CHILDREN // ... lead to a potentially dangerous enlargement of the heart, according ... Hopkins Children's Center and the Children's Hospital at Montefiore in ... children, at least, that the higher the blood pressure the ...
... with Actonel are more likely to sustain when ... in the peer-reviewed journal Osteoporosis International after collecting ... ,The study of 33,000 postmenopausal women showed that ... most popular osteoporosis treatments, patients taking Actonel? (risedronate ...
... Support to Primary Education (commonly known as Mid-Day Meal ... the world //covering nearly 12 crore children in more ... Innovative Education (AIE) centers. ,The scheme provides ... and 12 gms of protein. The Scheme has been ...
... conducted a survey on “Man Flu”. "Man flu," is that mysterious ... barely seem to affect their female counterparts, " according to Nuts, ... per cent of men had Flu, that forced them to stay ... cent of women said the same. The survey also revealed that ...
... exercise works well for weight loss, but dieters end up ... want to lose weight in their 50s and 60s, to ... calories. ,Both, those who dieted and those who ... from the study on ‘whether a calorie-restriction diet can extend ...
... the stigma of the disease. // ,According to official ... to 1.56 percent in 2005, from 14.7 percent in 2001. ... cured are called, have been roped in since leprosy is on ... Ranchi has gone up to 1.60 percent between April and August, ...
Cached Medicine News:Health News:Children and Chronic Kidney Disease 2Health News:Children and Chronic Kidney Disease 3Health News:Actonel Treats Hip Fractures In A Better Way Than Alendronate 2Health News:Mid-Day Meal Scheme Catches on in India 2Health News:Which Is Better For Losing Weight? - Diet Or Exercise 2
The HEP-3, with a transfer area of 35cmW x 45cmL, is designed specifically for the transfer of nucleic acids from sequencing gels to nylon membranes....
... electrophoretic transfer cell and PowerPac 200 ... Transfers. Minimal Buffer Requirements. ... Reliable Transfers. Single-Step Locking System ... to Transfer Multiple Gels. New ...
PosiBlot 30-30 Sponges...
Ice block will provide sufficient cooling for most normal blotting applications. Sealed block is held submerged in transfer buffer. Ice block will not spill during refreezing....
Medicine Products: